3-Dimensional parylene scaffold cage

US9248013B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9248013-B2
Application numberUS-201313740069-A
CountryUS
Kind codeB2
Filing dateJan 11, 2013
Priority dateDec 5, 2011
Publication dateFeb 2, 2016
Grant dateFeb 2, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Thin parylene C membranes having smooth front sides and ultrathin regions (e.g., 0.01 μm to 5 μm thick) interspersed with thicker regions are disclosed. The back sides of the membranes can be rough compared with the smooth front sides. The membranes can be used in vitro to grow monolayers of cells in a laboratory or in vivo as surgically implantable growth layers, such as to replace the Bruch's membrane in the eye. The application further provides an implantable cage-like apparatus for culturing cells comprising the parylene membrane.

First claim

Opening claim text (preview).

What is claimed is: 1. A three-dimensional implantable apparatus for implanting cells comprising: a top portion comprising a top face joined to each of four side faces, wherein said top portion is configured to allow microvilli or other cellular processes to connect to an anatomical structure external to said implantable apparatus; a bottom portion comprising parylene having a first thickness and a second thickness; and a gap between the top portion and the bottom portion, wherein the bottom portion is joined with each of the four side faces, the gap being suitable for growth of cells to be implanted, wherein said cells are selected from the group consisting of cartilage cells, heart muscle cells, and retinal pigment epithelium (RPE) cells, wherein the first thickness of the bottom portion is configured to allow proteins having a molecular weight of 70 kilodaltons or less to move through the bottom portion and to inhibit movement of proteins having a molecular weight greater and 100 kilodaltons through the bottom portion, and wherein the second thickness of the bottom portion is greater than the first thickness of the bottom portion. 2. The three-dimensional implantable apparatus of claim 1 , wherein the parylene comprises parylene C. 3. The three-dimensional implantable apparatus of claim 2 , wherein the parylene C is between 0.1 μm to 10 μm thick. 4. The three-dimensional implantable apparatus of claim 2 , wherein the parylene C is between 0.15 μm to 0.8 μm thick. 5. The three-dimensional implantable apparatus of claim 1 , wherein the implantable apparatus consists entirely of a biocompatible material suitable for implantation in a human or animal body. 6. The three-dimensional implantable apparatus of claim 1 , wherein said bottom portion has permeability similar to a Bruch's membrane. 7. The three-dimensional implantable apparatus of claim 1 , wherein said bottom portion allows diffusion of cell nutrients and cell waste through the semi-permeable membrane to cells, facilitating cell growth as a monolayer on the membrane. 8. The three-dimensional implantable apparatus of claim 1 , wherein said top portion blocks cell migration. 9. A three-dimensional implantable apparatus for implanting cells, comprising: a top portion comprising a top face joined to each of four side faces, wherein said top portion is configured to block cell migration but allow microvilli or other cellular processes to connect to an anatomical structure external to said implantable apparatus; a bottom portion having a first thickness and a second thickness; and a gap between the top portion and the bottom portion, wherein the bottom portion is joined with each of the four side faces, the gap being suitable for growth of cells to be implanted, wherein said cells are selected from the group consisting of cartilage cells, heart muscle cells, and retinal pigment epithelium (RPE) cells, wherein the first thickness of the bottom portion is configured to have a thickness between 0.01 μm and 5 μm, and wherein the second thickness of the bottom portion is at least 2 times thicker than the first thickness of the bottom portion.

Assignees

Inventors

Classifications

  • Macromolecular materials · CPC title

  • characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title

  • C12N5/0068Primary

    General culture methods using substrates (for specific animal cell type C12N5/06) · CPC title

  • Designing or manufacturing processes · CPC title

  • Prostheses implantable into the body · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9248013B2 cover?
Thin parylene C membranes having smooth front sides and ultrathin regions (e.g., 0.01 μm to 5 μm thick) interspersed with thicker regions are disclosed. The back sides of the membranes can be rough compared with the smooth front sides. The membranes can be used in vitro to grow monolayers of cells in a laboratory or in vivo as surgically implantable growth layers, such as to replace the Bruch's…
Who is the assignee on this patent?
California Inst Of Techn, Univ Southern California
What technology area does this patent fall under?
Primary CPC classification C12N5/0068. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).